Posts by Sandra Ansanay-Alex
Lonza to stop producing Moderna vaccine in Visp
Production of the Moderna serum will cease at Visp in the canton of Valais. In addition, Lonza’s Managing Director, Pierre-Alain Ruffieux, is stepping down and will be replaced ad interim by Albert Baehny, 71. Pierre-Alain Ruffieux, CEO of Lonza since 1 November 2020, will down from his post at the beginning of October, Albert…
Read MoreSocorex, 60 years of success in precision volumetry
The story begins in 1963, in Canton of Vaud (Switzerland) with the know-how gathering of small companies active in manufacturing medical and dental syringes, needles and cannulas. Thanks to a new production site in Ecublens and a consolidated range of reliable, robust medical instruments and accessories, Socorex quickly became a success on the Swiss and…
Read MoreCUTISS AG launches its Series C funding round
CUTISS AG, a Swiss company specialising in regenerative skin medicine and tissue engineering, has announced the launch of its Series C funding round. This milestone aims to support the development of its personalised skin therapy, denovoSkin™, following successful Phase 2 clinical trials. CUTISS also plans to finalise the clinical preparation of an automated machine…
Read MoreAmal Therapeutics wins Geneva Innovation Prize
Les Grands Prix de l’économie 2023 are organised by the CCIG, with the support of the State of Geneva and the Office de Promotion des Industries et des Technologies (OPI). The Innovation Prize went to Amal Therapeutics, which specialises in cancer treatment and prevention. This spin-off from the University of Geneva and the…
Read MoreA new brain cell discovered by Swiss researchers
The two major families of cells that make up the brain, neurons and glial cells, secretly hid a hybrid cell, halfway between these two categories. The discovery, made by a team of University of Lausanne (UNIL) and Wyss Center for Neuro and Bio Engineering in Geneva, could transform our understanding of brain function and dysfunction.…
Read MoreHAYA Therapeutics is Switzerland’s most promising startup
The 13th edition of the TOP 100 Swiss Startup Award celebrated Switzerland’s best startups according to a 100-person strong jury: HAYA Therapeutics (1st), Planted Foods (2nd), and Yokoy Group (3rd) lead the ranking. First place: HAYA Therapeutics | Epalinges (VDà The biotech startup HAYA Therapeutics develops precision drugs. The lead candidate for cardiac fibrosis…
Read MoreA breakthrough in the US for Antion Biosciences SA
Antion Biosciences SA (Antion), an innovative developer of cell and gene therapy technologies, announces the granting of a significant patent by the United States Patent and Trademark Office (USPTO). The awarded patent, identified as US Patent No. US 11,649,455, further strengthens Antion’s position as a leading innovator in the cell and gene therapy…
Read MoreAgora Care partners with PRISTEM SA
Two Western Switzerland startups join forces to revolutionize medical imaging Agora Care is a Geneva-based company developing a patient-centered platform for storage and communication of medical images. The Agora Care solution will give patients the opportunity to be fully in control of their medical images using a simple web-based platform allowing them to share…
Read MoreDeciphering the “highway code” of our cells
A team from UNIGE has identified a new process governing the growth of the ‘roads’ that enable cells to thrive. Just as a city needs efficient transportation networks for its exchanges and development, cells require ‘roads’ to ensure their supply, growth, and division. These are called microtubules. They are dynamic structures that continually assemble…
Read Moreten23 health expands sterile manufacturing capacity at its VIVA 1® facility in Visp
ten23 health®, a global contract development and manufacturing organization, announced a capacity expansion for the manufacture of sterile drug product at its Visp facility. This will help to meet rapidly increasing customer demand. With customer demand for sterile fill & finish services increasing, ten23 health is expanding the available capacity at its VIVA 1®,…
Read More